Hello again, my pharmacy stars
Shigeoka, T., Nomiyama, T., Kawanami, T., Hamaguchi, Y., Horikawa, T., Tanaka, T., Irie, S., Motonaga, R., Hamanoue, N., Tanabe, M., et al
GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes
What do we know about what the body is going to do after 25 years on this drug, or how it interacts with some of the other natural aging processes, the way our bodies are naturally going to change when we're in our 60s or our 70s and we've been on this for 20 years
With GLP-1, dietary adjustments are necessary but not extreme to handle the muscle and intestinal effects of the drug
In addition to glucose management, Tirzepatide supports weight management, a crucial aspect of metabolic health